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mass spectrometry. No differences in lipid species composition were evident when the lipid extraction
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List of Abbreviations
BHT

Butylated hydroxytoluene

BSTFA

(N,O-bis(trimethylsilyl)trifluoroacetamide

CE

Collision energy

Cer

Ceramide

CerPCho

Sphingomyelin

ChoGpl

Choline glycerophospholipid

CV

Coefficient of variation

CXP

Collision cell exit potential

DP

Declustering potential

EP

Entrance potential

ESI-MS

Electrospray ionisation mass spectrometry

EtnGpl

Ethanolamine glycerophospholipid

GC-MS

Gas chromatography mass spectrometry

MTBE

Methyl-tert-butyl ether

MRM

Multiple reaction monitoring

NL

Neutral loss

PI

Precursor ion

PtdSer

Phosphatidylserine

SGalCer

Sulfatide

TMCS

Ttrimethylchlorosilane
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Abstract
We have developed a protocol suitable for high-throughput lipidomic analysis of human brain
samples. The traditional Folch extraction (using chloroform and glass-glass homogenisation)
was compared to a high-throughput method combining methyl-tert-butyl ether (MTBE)
extraction with mechanical homogenisation utilising ceramic beads. This high-throughput
method significantly reduced sample handling time and increased efficiency compared to
glass-glass homogenising. Furthermore, replacing chloroform with MTBE is safer (less
carcinogenic/toxic), with lipids dissolving in the upper phase, allowing for easier pipetting
and the potential for automation (i.e. robotics). Both methods were applied to the analysis of
human occipital cortex. Lipid species (including ceramides, sphingomyelins, choline
glycerophospholipids, ethanolamine glycerophospholipids and phosphatidylserines) were
analysed via electrospray ionisation mass spectrometry and sterol species were analysed
using gas chromatography mass spectrometry. No differences in lipid species composition
were evident when the lipid extraction protocols were compared, indicating that MTBE
extraction with mechanical bead homogenisation provides an improved method for the
lipidomic profiling of human brain tissue.

Keywords
Lipidomics, human-brain, ceramide, sphingomyelin, phosphatidylcholine,
phosphatidylethanolamine, phosphatidylserine, sterol
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Introduction
It is established that lipid metabolism changes profoundly during human brain
development and ageing (1-2). There is also increasing evidence indicating that neurological
disorders including Parkinson’s disease (3-4), Alzheimer’s disease (5-6), Huntington’s
disease (7) and Schizophrenia (8) are all associated with alterations in cerebral lipid
homeostasis. In the case of Alzheimer’s disease, three of the strongest genetic risk factors for
the common late-onset form of the disease, i.e. APOE, CLU, ABCA7, are involved in brain
lipid transport (9-10). This highlights the fact that altered brain lipid metabolism may not
only be a consequence of the disease process but may in fact represent a causative factor that
could be amenable to therapeutic targeting. There is clearly a great need to develop efficient
methods that will facilitate the post-mortem analysis of human brain tissues by highthroughput lipidomic approaches. Such a method will help to clarify the extent to which
altered lipid metabolism is associated with various human neurological conditions and may
aid in the discovery of biomarkers for disease status as well as in monitoring treatment
efficacy (11). In the present study we aimed to develop an improved method that could
provide an alternative for the widely used Folch extraction / glass-glass homogenisation
method.
Shotgun lipidomics involves the analysis of a crude lipid extract via electrospray
ionization mass spectrometry (ESI-MS; see (12)). With recent advances in mass
spectrometry, such as the employment of automated chip-based nanospray technology, the
bottleneck for modern shotgun lipidomic studies is the time required for traditional lipid
extraction. A typical lipid extraction usually follows the Folch extraction (13), which
employs chloroform/methanol (2:1, by vol) and is generally accompanied by glass-glass
homogenisation. Although this method has become well-established over the last half century
as one of the most popular lipid extraction techniques, there are some disadvantages, in terms
4

of both safety and efficiency that need to be addressed. In particular, chloroform is highly
toxic and carcinogenic. Previous lipid studies have solved this toxicity issue to some degree
by replacing chloroform with dichloromethane (see 14, 15). However, both these solvents are
very dense, which is inconvenient during lipid extraction, as the lipids will dissolve in the
lower chloroform layer during phase separation (i.e. difficult to pipette without contamination
from the aqueous layer and also less compatible with the potential use of robotics). In
addition to this, glass-glass homogenisation is highly time-consuming and also increases the
risk of cross-contamination between samples.
An alternative to traditional glass-glass homogenisation is a new high-throughput
technology that employs mechanical bead beater homogenisation capable of homogenising
up to 96 samples within approximately two minutes. The risk of cross-contamination is also
limited, as single-use disposable tubes containing ceramic beads are used for each sample.
Variation between operators is also reduced as the mechanical bead homogenisation is
automated, making results more consistent and reproducible. Previous studies have processed
normal and diseased human brain tissue for the measurement of fatty acid composition (1617), with bead homogenisation results comparable to Potter-Elvehjem homogenisation
(equivalent to glass-glass). Other metabolomic studies have also employed automated bead
homogenisation for extraction and quantification of lipids (including glycerophospholipids
and sphingolipids) from various tissue matrices, including mouse brain, kidney, liver, adipose
tissue and muscle (18), as well as fish liver (19). However, a direct comparison of the Folch
glass-glass homogenisation method with a mechanical bead homogenisation has not been
previously investigated.
A recent lipidomic study demonstrated that methyl-tert-butyl ether (MTBE) can
effectively replace chloroform for the extraction of lipids from tissue matrices (including
mouse brain, Caenorhabditis elegans eggs and Escherichia coli; see (20)). This MTBE
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extraction protocol has also been applied to measure lipids in cerebrospinal fluid of
Alzheimer’s disease patients (21-22). A Bligh and Dyer (23) variation of this MTBE protocol
has also been utilised in previous lipidomic studies of human plasma (20, 24-26). The main
advantages of MTBE over chloroform are its lower toxicity and density (so that lipids
dissolve in the upper layer during phase separation), which greatly improves safety and ease
of sample processing (see (20) for more details).
To overcome the aforementioned problems associated with traditional lipid extraction
techniques, protocol comparisons were made between the well-established Folch extraction
(using glass-glass homogenisation; i.e. “Glass-Chloroform”) and a modified method that
employed bead homogenisation (Precellys®24) and, based on (20), replaced chloroform with
MTBE (i.e. “Bead-MTBE”). The lipid composition of human occipital cortex was measured
as a test sample. The lipid species measured by ESI-MS included: ceramides (Cer),
sphingomyelins (CerPCho), choline glycerophospholipids (ChoGpl), ethanolamine
glycerophospholipids (EtnGpl) and phosphatidylserines (PtdSer). In combination with this
“shotgun” approach, the lipid extracts of human brain tissue were also subjected to a more
targeted analysis of sterol species via gas chromatography mass spectrometry (GC-MS).

Materials and Methods
Materials and internal standards
MTBE, chloroform, methanol, acetone, hexane and acetonitrile were HPLC grade and
purchased from Thermo Scientific, Scoresby, VIC, Australia; analytical grade butylated
hydroxytoluene (BHT) and sodium hydroxide (98% minimum) from Sigma Aldrich, Sydney,
NSW, Australia; analytical grade ammonium acetate from Crown Scientific, Moorebank,
NSW, Australia; 15 x 45 mm (4 mL) screw thread vials and 12 x 32 mm (1.8 mL) wide
6

mouth vials (both with PTFE/silicone septa caps) from Grace Davison, Rowville, VIC,
Australia. All solvents contained 0.01% w/v BHT.
Two internal standard mixtures were added to each sample. Firstly, 4 µL/mg of tissue
of the phospholipid/sphingolipid standard mixture containing: 75 µM CerPCho(d18:0/12:0),
75 µM Cer(d18:1/10:0), 500 µM PtdCho(19:0/19:0), 175 µM PtdSer(17:0/17:0), 225 µM
PtdEtn(17:0/17:0), 25 µM Lyso PtdCho (17:0) and 25 µM Lyso PtdEtn (14:0) in
chloroform/methanol (2:1, by vol); Avanti Polar Lipids purchased from Auspep, Tullamarine,
VIC, Australia. Secondly, 10 µL/sample of sterols standard mixture in ethanol was added,
including: desmosterol-d6, 14-demethyl-lanosterol-d6, (Avanti Polar Lipids), -sitosterol-d7,
campesterol-d3 and 7-ketocholesterol-d7 (CDN Isotopes, Quebec, Canada) and 27hydroxycholesterol-d5 and 24-hydroxycholestero-d7 (Medical Isotopes, Inc, Pelham, AL,
USA). Lanosterol, squalene, stigmasterol and 24,25-dihydrolanosterol were quantitated using
other heavy sterol internal standards.

Human brain tissue
The human brain tissue was collected with written informed consent as approved by
the Human Research Ethics Committee of the University of New South Wales (HREC0937)
in conformity with accepted international standards following the Declaration of Helsinki.
The use of human brain tissue for this project was approved by the University of Wollongong
Human Research Ethics Committee (HE10/327). Approximately 1 g of frozen human
occipital cortex from a neurologically normal male (81 years of age, post-mortem delay 3
hours) was received from the Sydney Brain Bank (Project # PID0154). The frozen brain
tissue was pulverised on dry ice and aliquots of approximately 10 mg were accurately
weighed and stored at -80°C prior to analysis. Each protocol included three replicates (n=3).
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Additional validation of the lipid extraction protocol was undertaken using frozen
human anterior cingulate cortex from three neurologically normal males. Ages were 60, 78
and 88 years with post-mortem delay of 25, 6.5 and 9 hours respectively.

Lipid extraction
A comparison of the two lipid extraction methods is shown in Figure 1 and each is
described in detail below.
Traditional Glass-Chloroform
This protocol was based on the traditional Folch extraction (13) with modifications
previously described (see 3, 27, 28). Each 10 mg pulverised brain aliquot was homogenised
on ice with a glass-glass homogeniser (1mL Tenbroeck Tissue Grinder; Edwards Instrument
Company, Narellan, NSW, Australia) in 500 µL methanol containing internal standards (plus
166 µL methanol to rinse homogeniser). The homogenate was transferred to a 4 mL vial and
1332 µL chloroform added (chloroform/methanol 1:2, by vol). The homogenate was split,
with 1/3 transferred to a separate 4 mL vial (for phospholipid analysis), while the remaining
2/3 was used for sphingolipid and sterol analysis. Both fractions were treated equally except
for the addition of sodium hydroxide (final concentration 0.7M) to the sphingolipid and sterol
fraction (to promote hydrolysis of phospholipid ester linkages). Following overnight rotation
at 4°C, 0.15M ammonium acetate was added (chloroform/methanol/0.15M ammonium
acetate 8:4:3, by vol; 333 µL for sphingolipid/sterols and 167 µL for phospholipids), the
sample centrifuged (10 minutes at 2000 x g at 4°C) and the chloroform phase (lower phase)
containing lipids transferred to a new 4 mL vial. Chloroform/methanol (1:2, by vol) was
added to the original homogenate (equivalent to original volume), centrifuged as above and
the lower phase combined with the first chloroform extract. A second phase separation was
performed on this chloroform extract by adding 0.15M ammonium acetate (333 µL for
8

sphingolipid/sterols and 167 µL for phospholipids), centrifuging as above and transferring the
lower phase to a new 4 mL vial (1.8 mL vial for phospholipid fraction), which was then dried
under nitrogen at 37°C. The phospholipid fraction was resuspended in 300 µL
chloroform/methanol (1:2, by vol). The volume for the sphingolipid and sterol fraction was
700 µL, with half (350 µL) transferred to a 1.8 mL vial for sphingolipid analysis and the
remainder (350 µL) used for sterol analysis (see below for derivitisation procedures). All
phospholipid and sphingolipid extracts were stored at -80°C prior to analysis via ESI-MS.
Bead-MTBE
The MTBE extraction was modified from (20) with Precellys®24 settings based on
previous work (16). Each 10 mg pulverised brain aliquot was weighed directly into a 0.5 mL
Precellys tube (Sapphire Bioscience, Waterloo, NSW, Australia) and homogenised in 300 µL
ice-cold methanol containing internal standards, using a Precellys®24 (Bertin Technologies;
2 x 30 sec at 6000 rpm). After transferring the homogenate to a 4 mL glass vial the Precellys
tube was rinsed with 162 µL methanol and 1540 µL MTBE added to the glass vial
(MTBE/methanol 10:3, by vol). The homogenate was split into phospholipids and
sphingolipid/sterol fractions as described above. Following overnight extraction/hydrolysis,
0.15M ammonium acetate was added (MTBE/methanol/0.15M ammonium acetate 20:6:5, by
vol; 253 µL for sphingolipid/sterols and 127 µL for phospholipids), the sample centrifuged
(as above) and the organic phase (upper phase) collected in a 4 mL vial. The original
homogenate was re-extracted by addition to the upper phase of MTBE/methanol/0.15M
ammonium acetate (20:6:5, by vol; 205 µL for sphingolipid/sterols and 411 µL for
phospholipids), followed by centrifugation and combining the upper phase with the first
extract. This lipid extract was then dried under nitrogen at 37°C and resuspended in
chloroform/methanol (1:2, by vol) as described above.
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Mass spectrometry & lipid analysis settings
Phospholipid and sphingolipid extracts were analysed via ESI-MS using a hybrid
triple quadrupole ion trap mass spectrometer (QTRAP® 5500, AB SCIEX, Framingham,
Massachusetts, USA) and an attached chip-based, automated nanospray source (Triversa
Nanomate®, Advion, Ithaca, NY, USA). See Table 1 for ESI-MS settings. Prior to
introduction on the mass spectrometer lipid extracts were diluted 1/50 with
chloroform/methanol (1:2, by vol) and ammonium acetate was added (final concentration
5µM). Samples (50 µL) were loaded onto a 96-well plate, sealed with foil and centrifuged for
10 minutes at 2204 x g (Eppendorf Centrifuge 5430). The spray parameters were set with a
gas pressure of 0.4 psi and voltage applied at 1.2 and 1.1 kV for positive and negative mode
respectively. Multi-channel acquisition (MCA) was employed for sphingomyelin and
ceramide precursor ion scans only.
Phospholipid and sphingolipid species were quantified using AB SCIEX Lipidview™
Software (Framingham, Massachusetts, USA; see 29). The processing settings for
Lipidview™ were: mass tolerance 0.5 and minimum % intensity 0 (all species) and minimum
S/N 50 (Cer, CerPCo, ChoGpl, EtnGpl) or 0 (PtdSer). Head group scans were used to quantify
each lipid species (see Table 1) and the fatty acyl chain scans were used to determine each
molecular species (for phospholipids only). Masses that could be assigned to ether or oddchain fatty acids were assumed to be ether-linked phospholipids. Where two or more isomeric
species from the same class were detected the relative proportion of the peak areas from each
fatty acyl scan was used to calculate the final corrected areas for each molecular species. For
example, ChoPCo (16:0/18:1) and ChoPCo (18:0/16:1) made up 95 and 5% of total ChoPCo
34:1 peak areas respectively. Any species < 0.5% of lipid class were removed from the
analysis. Ether-linked EtnGpl do not produce the neutral loss of 141 Da to the same extent as
diacyl EtnGpl (30) and previous work in our group has demonstrated that plasmalogens
10

produce the 141 NL at about 29% the efficiency of diacyl EtnGpl (31). As a diacyl internal
standard was used to quantify all EtnGpl in the present study, an experimentally determined
correction factor of 3.45 was applied to the ether-linked EtnGpl data (T. Mitchell, unpublished
data). For ceramide the characteristic ions were [M+H]+ and [M-H2O]+ for each species. The
peak areas for both ions were exported from Lipidview™, combined and corrected against the
combined peak areas from the internal standard.

Sterol derivatisation and GC-MS settings
The sterol fraction of the lipid extract (from both protocols) was dried down under
nitrogen at 37°C and the following added: 1.5 mL 0.1M hydrochloric acid, 1.5 mL 80mM
acetic acid, 250 µL 1M sodium hydroxide and 250 µL methanol (pH of final solution ~ 4.75).
Solid phase extraction columns (Waters Oasis Max 3cc; Waters, Rydalmere, NSW, Australia)
were preconditioned with 2 mL methanol and 2 mL 40mM acetate buffer (pH 4.5). The
sample was then loaded and washed with 2 mL 30% methanol 40mM formic acid (pH4.5).
Sterol fractions were eluted with 1.8 mL hexane followed by 1.8 mL acetone/hexane (30:70,
by vol) and then dried down under nitrogen at 37°C. Samples were then derivatised by the
addition of 20 µL acetonitrile and 20 µL Selectra-SIL BSTFA (N,Obis(trimethylsilyl)trifluoroacetamide) containing 1% TMCS (trimethylchlorosilane; United
Chemical Technologies, purchased from PM Separations, QLD, Australia) and incubation for
one hour at 37°C.
After drying under nitrogen at 37°C and reconstitution in 30 uL toluene, derivatised
samples were analysed by an Agilent 7000B triple quadrupole mass selective detector
interfaced with an Agilent 7890A GC system gas chromatograph, equipped with an automatic
sampler and a computer workstation. The injection port and GC-MS interface were kept at
280°C. Separations were carried out on a fused silica capillary column (30 m x 0.2 mm i.d.)
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coated with cross-linked 5% phenylmethylsiloxane (film thickness 0.33µm; Agilent, J and
W). Helium was the carrier gas with a flow rate of 1.2 ml/min (average velocity = 59 cm/sec).
Derivatised samples (1 µl) were injected splitless into the GC injection port. Column
temperature was increased from 165°C to 270°C at 30°C/min after 1 min at 165°C, then
temperature was raised to 300°C at 5°C/min and held at 300°C for 4 min. Selected-reaction
monitoring was performed using the PCI mode using methane as the reagent gas (4 ml/min),
Argon as the collision gas (1.5 ml/min) and 2.25 ml/min atomic He in the collision cell to
reduce chemical noise from metastable He. The ion source was maintained at 280°C and the
quadrapoles at 150°C. Table 2 lists the target ion transitions that were monitored for each
sterol species.

Statistical analysis
Statistical analysis was performed using JMP 9.0 (SAS Institute Inc., NC, USA). All
results are expressed as mean ± S.E.M. with p<0.05 set as the level of significance. Data was
tested for normality using Shapiro-Wilk W test and homogeneity of variance using a 2-sided
F Test. Student’s t tests were used for comparisons between treatments (Bead-MTBE versus
Glass-Chloroform) for each lipid species.

Results and Discussion
Data resulting from the quantification of human occipital cortex lipids that were
solvent-extracted using either the Glass-Chloroform or Bead-MTBE methods are presented in
a similar format in all figures. The results for the sphingolipids, Cer and CerPCho, are shown
in Figure 2 and Figure 3 respectively. The glycerophospholipids, ChoGpl, EtnGpl and
PtdSer, are shown in Figure 4, Figure 5 and Figure 6 respectively. In each of these figures,
representative head group spectra from the Bead-MTBE extraction are found in the top panel
12

(a) and the Glass-Chloroform in the middle panel (b). Comparison of these representative
spectra for each lipid class reveals no obvious difference between the two methods, in terms
of ions present or the maximum ion intensity (see Figure 2 – 6; “a” versus “b”). This
indicates that the recovery levels were similar for both methods.
The lower panel (c) in Figures 2 - 6 show the quantified concentrations for each lipid
class (nmol/g tissue wet weight). The most abundant lipid species in the human occipital
cortex was ChoGpl (total~19000 nmol/g tissue), followed by EtnGpl (~8000 nmol/g tissue)
and PtdSer (~6000 nmol/g tissue), CerPCho (~4000 nmol/g tissue), with much lower levels of
ceramide present (~600 nmol/g tissue). No significant difference between Bead-MTBE and
Glass-Chloroform methods was evident for the total levels of each lipid class (p > 0.28).
Looking in more detail firstly at the sphingolipids, we identified 13 ceramide species
using both extraction methods (Figure 2c). The most abundant species were Cer(d18:1/18:0)
and Cer(d18:1/24:1). Only Cer(d18:1/18:0) showed a significant increase (15%) in
concentration in the Bead-MTBE extraction (p = 0.027). For sphingomyelin, 15 species were
identified (Figure 3c). The major species present were: CerPCho(d18:1/18:0),
CerPCho(d18:1/24:1) and CerPCho(d18:1/20:0). No significant difference between extraction
protocols was evident in the level of any CerPCho species (p > 0.14).
In terms of the glycerophospholipids, 22 ChoGpl species were present in the human
occipital cortex (20 diacyl and 2 ether), with ChoGpl(16:0/18:1) and ChoGpl(16:0/16:0) the
most abundant species (Figure 4c). No difference between the two methods was observed for
ChoGpl analysis (p > 0.11). A total of 33 EtnGpl species were identified (18 diacyl and 15
ether species), with EtnGpl(18:0/22:6) by far the most abundant species present (Figure 5c).
Only EtnGpl(O-16:1/22:5) and EtnGpl(O-18:2/20:4) showed a significant increase (27%
each) using the Bead-MTBE extraction method (p = 0.022 for both). Ether-linked EtnGpl
species were present at 35% of total EtnGpl in human occipital cortex. This value
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corresponds with the plasmalogen levels present in normal human brains in previous studies,
with values varying from 23% in human anterior cingulate cortex and primary visual cortex
(3), up to 56% of total EtnGpl in temporal cortex grey matter (32).
No significant difference between the two protocols was observed for the PtdSer
analysis (p > 0.38; Figure 6c). Of the 17 PtdSer species quantified, PtdSer(18:0/18:1) and
PtdSer(18:0/22:6) were present at the highest levels. Results for the lysoglycerophospholipids
were consistent with their diacyl counterparts, with 12 species of lyso-ChoGpl and 10 species
of lyso-EtnGpl quantified (results not shown). No significant difference between extraction
methods was found for lyso-ChoGpl (p > 0.11) or lyso-EtnGpl (p > 0.09).
Both extraction protocols were also employed in the quantification of sterol species in
the human occipital cortex (Figure 7). Representative spectra are not shown as the quantified
values were obtained using targeted multiple reaction monitoring (MRM). No significant
differences were found for any sterol species when the Bead-MTBE and Glass-Chloroform
extraction methods were compared (Figure 7). The sterol species identified included
cholesterol precursors (squalene, lanosterol, 14-demethyl lanosterol, desmosterol and 24,25dihydrolanosterol), oxysterols (7keto-cholesterol, 27-hydroxycholesterol and 24hydroxycholesterol) and phytosterols (campesterol, stigmasterol and β-sitosterol). Of the
species identified, 24-hydroxycholesterol was the most highly abundant sterol species present
in the human occipital cortex which is consistent with previous data (3). As an additional
measure, total free cholesterol was quantified using ESI-MS (with lathosterol-d4 as an
internal standard). In the occipital cortex cholesterol mean values were 411 ng/mg wet tissue
weight (results not shown). No significant difference in cholesterol levels between the two
protocols was detected (p = 0.6842).
To further validate the Bead-MTBE extraction method, we compared the sphingolipid
composition of three different control subjects from a different brain region (anterior
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cingulate cortex). Sphingomyelin and ceramide levels in human anterior cingulate cortex are
shown in Figure 8. The sphingolipid species identified were the same as for occipital cortex
(see Figure 2 and Figure 3). For sphingomyelin, only CerPCho(d18:1/18:1) showed a
significant increase in concentration in the Bead-MTBE extraction (p = 0.033). Three
ceramide species demonstrated a significant difference between the two protocols, including
Cer(d18:1/16:0), Cer(d18:1/22:1) and Cer(d18:1/23:1), with p-values of 0.034, 0.001 and
0.017 respectively. The sphingolipid species with significant differences between the two
protocols were all low abundance species. These results are comparable to the single occipital
cortex sample and demonstrate that there are no major differences between the two methods
when samples from multiple donors are analysed.
From these studies we conclude that the high-throughput Bead-MTBE protocol is
equivalent to the traditional Glass-Chloroform protocol for lipid extraction and quantification
of glycerophospholipid, sphingolipid and sterol species in human brain tissue. Furthermore,
the average variation for each lipid class was also similar, with the following coefficient of
variation (CV) values for Bead-MTBE and Glass-Chloroform respectively: Cer, 20.1% and
23.3%; CerPCho, 25.3% and 17.0%; ChoGpl, 21.9% and 15.0%; EtnGpl, 21.4% and 13.1%;
PtdSer, 24.7% and 15.2%; and sterols, 22.4% and 23.5%. The data suggest that the BeadMTBE method may be slightly more efficient than the traditional Folch extraction using
glass-glass homogenisers for lipid extraction. From Figures 2 – 6 it is obvious that there is a
trend for increased levels of lipids detected using the Bead-MTBE extraction relative to
Glass-Chloroform extraction, with a significant increase in a small number of lipid molecular
species for Bead-MTBE (Cer and EtnGpl only). This indicates that lipid recoveries using this
new extraction method may be improved slightly.
As mentioned above, we observed significant increases in three lipid species with the
Bead-MTBE extraction in the present study (p < 0.05). It should be noted, however, that of
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the total 133 lipid species identified we would expect to find a significant difference for 5%
of these species by chance alone (i.e. 6 or 7 species). Therefore, with significant differences
for only three lipid species, we can safely conclude that there was no difference in lipid
composition results when Bead-MTBE and Glass-Chloroform extraction methods were
compared.
We based the MTBE extraction method used in the present study on our own
modified Folch protocol (see 27, 28), as opposed to the variation of Folch used in (20). That
is, we used 0.15M ammonium acetate instead of water for phase separation, as the use of a
salt should increase the partition coefficient and reduce the loss of lipids in the aqueous phase
(13). Although brain samples were homogenised in methanol in the current protocol, we also
tested homogenisation in 0.01% w/v ammonium acetate, followed by extraction with
MTBE/methanol (as per (20); results not shown). Results were similar to the sphingolipid and
glycerophospholipid classes quantified using Bead-MTBE and Glass-Chloroform, indicating
that homogenisation of brain tissue in methanol or 0.01% ammonium acetate is equivalent.
Based on the knowledge that sulfatides are known to be enriched in the brain (33), we
also determined the mol% distribution of sulfatide species in human occipital cortex (data not
shown). A total of 18 sulfatide species were identified. Only two minor species (SGalCer
41:2;2 and SGalCer 42:3;2) demonstrated a significant increase in the Bead-MTBE extraction
protocol, indicating that sulfatide brain levels can be accurately determined using the BeadMTBE lipid extraction method.
In addition to the comparison between the Bead–MTBE and Glass–Chloroform
extraction methods, we also tested the influence of increasing brain tissue amounts on the
extraction efficiency of MTBE/methanol for the various lipid classes (results not shown).
Total solvent volume remained constant (~2 mL) while increasing the amount of control
tissue to be extracted (i.e. 10, 20 and 40 mg). On average the variation between tissue
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amounts was ≤ 10% for all quantified glycerophospholipids (including ChoGpl, EtnGpl and
PtdSer), as well as CerPCho. The average variation for ceramide was higher (31%), with
significantly reduced quantitation levels at 20 and 40 mg tissue mass. The mol% values for
ceramide species within ceramide class appeared to be consistent, however, indicating that
the relative species distribution is maintained for up to 40 mg of tissue. This apparent lower
recovery of ceramide species at higher tissue:solvent ratios may be to due the much lower
abundance of this lipid class (for example, ChoGpl is present at 33 times the levels of Cer in
the occipital cortex). Therefore, although 2 mL MTBE/methanol is sufficient for the
quantification of glycerophospholipids and sphingomyelin in up to 40 mg brain tissue, if
ceramide is to be included in the analysis we would recommend increasing solvent volumes
accordingly to avoid under-estimation of this lipid class.
In summary, lipid profiling of human brain using MTBE extraction and mechanical
bead homogenisation was comparable to Folch extraction (i.e. chloroform) with glass-glass
homogenisation. This was true for sphingolipids (ceramide and sphingomyelin),
glycerophospholipids (choline glycerophospholipids, ethanolamine glycerophospholipids and
phosphatidylserine) and sterols. This high-throughput Bead-MTBE protocol improves upon
traditional lipid extraction methods as it is safer and much more efficient. The Bead-MTBE
protocol is approximately four times quicker than Glass-Chloroform in the homogenisation of
24 samples (i.e. 1 hour versus 4 hours), with the additional benefit being that tissue aliquots
can be weighed directly into the Precellys tubes prior to homogenisation (thus reducing
double-handling times). The lower density of MTBE further enhances the lipid extraction
procedure (by dissolving lipids in the upper phase) and is also better for the potential
incorporation of robotics to further streamline lipidomic studies.
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Table1: ESI-MS settings for phospholipid and sphingolipid analysis of human brain occipital
cortex. Scan rate was set at 200 Da/s for all scan types. Precursor ion (PI); neutral loss (NL);
declustering potential (DP); entrance potential (EP); collision energy (CE); collision cell exit
potential (CXP).
Lipid

Ion Mode

Scan Type

DP

EP

CE

CXP

Range

Head group scans
Cer

+ve

PI 264.4 m/z

120

14

35

10

400-700

CerPCo

+ve

PI 184.2 m/z

100

12

50

15

600-900

ChoGpl

+ve

PI 184.1 m/z

100

10

47

8

450-880

EtnGpl

+ve

NL 141 Da

100

10

30

8

420-830

PtdSer

+ve

NL 185 Da

100

10

30

8

650-830

Fatty acyl chain scans
14:0

-ve

PI 227.2 m/z

-100

-10

-55

-11

400-900

16:1

-ve

PI 253.2 m/z

-100

-10

-55

-11

600-900

16:0

-ve

PI 255.2 m/z

-100

-10

-55

-11

400-900

17:0

-ve

PI 269.3 m/z

-100

-10

-55

-11

560-900

18:3

-ve

PI 277.2 m/z

-100

-10

-55

-11

600-900

18:2

-ve

PI 279.2 m/z

-100

-10

-55

-11

600-900

18:1

-ve

PI 281.3 m/z

-100

-10

-55

-11

600-900

18:0

-ve

PI 283.3 m/z

-100

-10

-55

-11

600-900

19:0

-ve

PI 297.3 m/z

-100

-10

-55

-11

600-900

20:5

-ve

PI 301.2 m/z

-100

-10

-55

-11

500-900

20:4

-ve

PI 303.2 m/z

-100

-10

-55

-11

600-900

20:3

-ve

PI 305.2 m/z

-100

-10

-55

-11

600-900

20:2

-ve

PI 307.2 m/z

-100

-10

-55

-11

600-900

20:1

-ve

PI 309.2 m/z

-100

-10

-55

-11

600-900

22:6

-ve

PI 327.2 m/z

-100

-10

-55

-11

740-900

22:5

-ve

PI 329.2 m/z

-100

-10

-55

-11

740-900

22:4

-ve

PI 331.2 m/z

-100

-10

-55

-11

740-900

22:3

-ve

PI 333.3 m/z

-100

-10

-55

-11

600-900
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Table2: Target ion transitions used for GC-MS analysis of sterols in human brain occipital
cortex.

Compound

Target ion transition m/z → m/z
(Collision energy)

Squalene

327→ 203 (5)

(H)14-demthyl-lanosterol

475→ 399 (6)

14-demthyl-lanosterol

469→ 393 (4)

(H) Desmosterol

461→ 371 (10)

Desmosterol

455→ 365 (8)

(H) Campesterol

474→ 384 (8)

Campesterol

471→ 381 (8)

24,25-Dihydrolanosterol

500→ 395 (10)

Stigmasterol

395→ 255 (5)

(H) β-Sitosterol

478→ 75 (30)

β-Sitosterol

471→ 75 (25)

Lanosterol

483→ 393 (3)

(H) 24-Hydroxycholesterol

462→ 372 (8)

24-Hydroxycholesterol

455→ 365 (3)

(H) 7-Ketocholesterol

480→ 390 (20)

7-Ketocholesterol

473→ 383 (10)

(H) 27-Hydroxycholesterol

462→ 161 (15)

27-Hydroxycholesterol

457→ 161 (20)
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Figure legends:
Figure 1: Flowchart comparing lipid extraction methods: “Glass-Chloroform” versus “BeadMTBE”; (I.S., internal standards; MTBE, methyl-tert-butyl ether; BHT, butylated
hydroxytoluene; ESI-MS, electrospray ionisation mass spectrometry; GC-MS, gas
chromatography-mass spectrometry)

Figure 2: Comparison of ceramide species identified in human occipital cortex using either
the Bead-MTBE or Glass-Chloroform method. ESI-MS precursor ion scan targeting
264 m/z for: a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c) Quantification of
brain ceramide species using both methods (Bead-MTBE = black bars; Glass-Chloroform =
grey bars); n = 3 per group; error bars show ± S.E.M. * p < 0.05.

Figure 3: Comparison of sphingomyelin (CerPCho) species identified in human occipital
cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS precursor ion scan
targeting 184 m/z for: a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c)
Quantification of brain sphingomyelin species using both methods (Bead-MTBE = black
bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show ± S.E.M.

Figure 4: Comparison of choline glycerophospholipid (ChoGpl) species identified in human
occipital cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS
precursor ion scan targeting 184 m/z for: a) Bead-MTBE extraction; b) Glass-Chloroform
extraction; c) Quantification of brain choline glycerophospholipid species using both methods
(Bead-MTBE = black bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show
± S.E.M.
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Figure 5: Comparison of ethanolamine glycerophospholipid (EtnGpl) species identified in
human occipital cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS
neutral loss scan targeting 141 Da for: a) Bead-MTBE extraction; b) Glass-Chloroform
extraction; c) Quantification of brain ethanolamine glycerophospholipid species using both
methods (Bead-MTBE = black bars; Glass-Chloroform = grey bars); n = 3 per group; error
bars show ± S.E.M.

Figure 6: Comparison of phosphatidylserine (PtdSer) species identified in human occipital
cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS neutral loss scan
targeting 185 Da for: a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c)
Quantification of brain phosphatidylserine species using both methods (Bead-MTBE = black
bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show ± S.E.M. * p < 0.05.

Figure 7: Comparison of sterol species identified in human occipital cortex using either the
Bead-MTBE or Glass-Chloroform method. Includes quantification of cholesterol precursors:
squalene (Squa), lanosterol (Lano), 14-demethyl-lanosterol (14-DL), desmosterol (Desmo),
24,25-dihydrolanosterol (24,25DHL); oxysterols: 7keto-cholesterol (7KC), 27hydroxycholesterol (27OHC), 24-hydroxycholesterol (24OHC); and phytosterols:
campesterol (Camp), stigmasterol (Stig) and β-sitosterol (βSit); Bead-MTBE = black bars;
Glass-Chloroform = grey bars; n = 3 per group; error bars show ± S.E.M.

Figure 8: Quantification of human anterior cingulate cortex sphingolipid species; a)
sphingomyelin; b) ceramide species using both extraction methods (Bead-MTBE = black
bars; Glass-Chloroform = grey bars); n = 3 different control subjects per group; error bars
show ± S.E.M. * p < 0.05.
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